Cargando…
Analysis of the survival of patients receiving systemic treatment for melanoma of the skin: a retrospective population study with patients treated in Poland in 2011–2015
INTRODUCTION: In Poland, it is uniquely possible to assess real effects of the introduction of new oncological therapies on the overall survival in patients as such therapies are funded by one payer only – the National Health Fund (NHF). Data collected by the NHF make it possible to analyse the surv...
Autores principales: | Brzozowska, Melania, Wierzba, Waldemar, Śliwczyński, Andrzej, Majkut, Gabriela, Jacyna, Andrzej, Orlewska, Ewa, Potemski, Piotr, Marczak, Michał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791149/ https://www.ncbi.nlm.nih.gov/pubmed/31616218 http://dx.doi.org/10.5114/ada.2019.83368 |
Ejemplares similares
-
Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015
por: Śliwczyński, Andrzej, et al.
Publicado: (2017) -
Syphilis in Poland is on the rise and underreported
por: Teter, Zbigniew, et al.
Publicado: (2019) -
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
por: Brzozowska, Melania, et al.
Publicado: (2019) -
Trends in psoriatic arthritis epidemiology in Poland
por: Tłustochowicz, Małgorzata, et al.
Publicado: (2020) -
Cost-effectiveness analysis of COVID-19 vaccination in Poland
por: Orlewska, Katarzyna, et al.
Publicado: (2021)